Through empowering and educating patients, funding cutting-edge research, building strategic collaborations and raising public awareness, our goal is to transform lung cancer into a chronically managed disease within 10 years and ultimately to find a cure.

Latest News
ALA and ALCF Momentum Award WinnerALA and ALCF Momentum Award Winner // The American Lung Association and ALCF announced that Dr. David Brian Shackelford, Assistant Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles,... Read More READ MORE
2016 Young Innovators Team Award Request for Applications2016 Young Innovators Team Award Request for Applications // ALCF announces third cycle of $500,000 funding for teams of young investigators. To learn more about guidelines and deadline for submission for our Young Innovator Team Awards, click here. READ MORE
September Living RoomSeptember Living Room // Don’t miss Lung Cancer Living Room Support Group September 20th, at 5:30PM PST! This month’s topic is a Patient Round Table about ALCF. Please join us online or in person! READ MORE
Cancer Moonshot Blue Ribbon Panel Unveils Recommendations to the National Cancer Advisory BoardCancer Moonshot Blue Ribbon Panel Unveils Recommendations to the National Cancer Advisory Board // Bonnie J. Addario Foundation Congratulates Vice President Biden and the Blue Ribbon Panel for their Work to Accelerate Cancer Research. This week, the Cancer Moonshot… Read More READ MORE
INVICTAN-2 Clinical Trial for Nonsquamous NSCLCINVICTAN-2 Clinical Trial for Nonsquamous NSCLC // A new clinical trial from Boehringer Ingelheim will be studying the safety and efficacy of a new drug call INVICTAN-2. The drug is similar to the biologic medication Avastin (bevacizumab)... Read More READ MORE